Niva Bupa Health Insurance Company Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
NIVABUPA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Niva Bupa reported gross premium written of Rs 8,58,592 lakhs for FY26, marking a 27% growth from Rs 6,76,223 lakhs in FY25. However, Profit After Tax declined significantly to Rs 13,078 lakhs from Rs 21,352 lakhs in the previous year, a drop of about 39%. The company continues to report underwriting losses of Rs 46,632 lakhs though operating profit improved to Rs 22,236 lakhs. The Expense of Management ratio improved to 33.70% from 39.22% previously. Solvency ratio remains healthy at 2.49. Joint statutory auditors issued an unmodified opinion but included an Emphasis of Matter regarding the company's pending EOM forbearance application with IRDAI for exceeding allowable expense limits in FY 2024-25. The company also has contingent liabilities including Rs 2,213 lakhs GST refund dispute and Rs 12,716 lakhs income tax demands.
The stock shows strong revenue growth but declining profitability may concern investors. The EOM ratio improvement is positive but pending IRDAI forbearance creates regulatory uncertainty. The healthy solvency ratio provides comfort on financial stability.